Loading...
Loading...
Application 2025361963 · 00
| Application Number | 2025361963 |
| Registration Number | 1877160 |
| Status | 00 |
| Mark Type | madrid |
| Owner | Just-Evotec Biologics, Inc. |
| Filed | 2025-09-25 |
| Registered | 2025-04-22 |
2025361963 has a current status of 00.
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Biological products, namely, engineered cells and cell culture reagents, for the recombinant expression and commercial production of proteins for use in scientific research, pharmaceutical research, veterinary biotechnology and industrial biotechnology.
Biological products in the nature of cells and reagents for medical or clinical use, namely, genetically modified cells and cell culture reagents, for the production of recombinant proteins for medical or pharmaceutical clinical use in human and animal therapies.
Research and development services in the field of biotechnology, namely, in the fields of molecular design, cell line engineering, and cell culture technology development, for recombinant protein expression or production.
| Name (romanised) | Just-Evotec Biologics, Inc. |
This device mark (application number 2025361963) is a 00 trademark on the Japan Patent Office register, filed by Just-Evotec Biologics, Inc. on 25 September 2025, with registration granted on 22 April 2025.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services), specifically covering: Biological products, namely, engineered cells and cell culture reagents, for the recombinant expression and commercial production of proteins for use in scientific research, pharmaceutical research, veterinary biotechnology and industrial biotechnology.; Biological products in the nature of cells and reagents for medical or clinical use, namely, genetically modified cells and cell culture reagents, for the production of recombinant proteins for medical or pharmaceutical clinical use in human and animal therapies.; Research and development services in the field of biotechnology, namely, in the fields of molecular design, cell line engineering, and cell culture technology development, for recombinant protein expression or production.
No — the Japan Patent Office records the status of Japanese trademark 2025361963 as 00.
Japanese trademark 2025361963 is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 1: Biological products, namely, engineered cells and cell culture reagents, for the recombinant expression and commercial production of proteins for use in scientific research, pharmaceutical research, veterinary biotechnology and industrial biotechnology. | Class 5: Biological products in the nature of cells…
Japanese trademark 2025361963 was filed at the Japan Patent Office on 25 September 2025 and registered on 22 April 2025.
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-28.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.